About Edinburgh Molecular Imaging
Edinburgh Molecular Imaging is a company based in Edinburgh (United Kingdom) founded in 2014 by Mark Bradley, Chris Haslett, and Kev Dhaliwal. Edinburgh Molecular Imaging has raised $10.68 million across 4 funding rounds from investors including Scottish Enterprise, European Union and Epidarex Capital. Edinburgh Molecular Imaging operates in a competitive market with competitors including Impedimed, Speclipse, OrSense, TumourTrace and Envue, among others.
- Headquarter Edinburgh, United Kingdom
- Founders Mark Bradley, Chris Haslett, Kev Dhaliwal
- SectorsTechnology
- Email••••••••
- Website emimaging.com
- Social LinkedIn X
- Legal Name Edinburgh Molecular Imaging Limited
- Date of Incorporation 13 Jan, 2014
- Jurisdiction EDINBURGH
- Net Profit-$1.26 M (USD)33as on Dec 31, 2018
- Total Equity Funding$10.68M (USD)
in 4 rounds
- Latest Funding Round$4.14M (USD), Series A
Dec 2019
- InvestorsScottish Enterprise
& 2 more
Funding Insights of Edinburgh Molecular Imaging
Edinburgh Molecular Imaging has successfully raised a total of $10.68M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $4.14 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.68M
- Total Rounds 4
- Last Round Series A — $4.14M
- First Round $6.54M
(Feb 2014)
- Investors Count 3
All 4 funding rounds of Edinburgh Molecular Imaging with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2019 | $4.14M | Series A | – | – | |
| Nov 2019 | $365,103 | Grant | – | – | |
| Jan 2019 | $365,103 | Grant | – | – | |
| Feb 2014 | $6.54M | Series A | – | Epidarex Capital, Scottish Enterprise | – |
3 investors in total: 3 institutional.
Investors in Edinburgh Molecular Imaging
Edinburgh Molecular Imaging has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Scottish Enterprise, European Union and Epidarex Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | epidarex.com | - | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Business development and leadership training programs are offered to companies. | 1991 | scottish-enterprise.com | Glasgow, United Kingdom |
Investor details for Edinburgh Molecular Imaging
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Edinburgh Molecular Imaging
9 people are tracked at Edinburgh Molecular Imaging (7 in leadership, 2 in board & advisors).
| Name | Role | Group |
|---|---|---|
Mark Bradley | Co-Founder | Leadership |
Chris Haslett | Co-Founder | Leadership |
Kev Dhaliwal | Co-Founder | Leadership |
Bernhard Sixt | CEO | Leadership |
Julian Lord | CFO | Leadership |
Alex Gibson | CEO | Leadership |
Lori Krim Gough | Director | Leadership |
Elizabeth Roper | Director | Board & advisors |
Rob James | Chairman | Board & advisors |
Complete people profiles for Edinburgh Molecular Imaging
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Edinburgh Molecular Imaging
3 dated milestones of Edinburgh Molecular Imaging across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Edinburgh Molecular Imaging is founded.
- Funding First funding round of $6.5M.
- Funding Latest funding round, Series A, of $4.1M.
Competitors of Edinburgh Molecular Imaging
Edinburgh Molecular Imaging operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Impedimed, Speclipse, OrSense, TumourTrace and Envue, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| impedimed.com | 1999 | Carlsbad, United States | $3.44M | 76 | Technologies for non-invasive fluid status assessment and monitoring are developed. | |
| speclipse.com | 2015 | Seongnam-si, South Korea | $10.55M | – | Molecular spectroscopy systems for early skin cancer detection are provided. | |
| orsense.com | 1996 | Petah Tikva, Israel | $33.2M | – | Non-invasive technology for body vitals measurement is developed and commercialized. | |
| tumourtrace.com | 2014 | Nottingham, United Kingdom | – | – | Offers early diagnostic tools for detecting solid tumors. | |
| envue-technologies.com | 2020 | Gothenburg, Sweden | – | – | Nanofluidic scattering microscopy technology for biomolecule imaging is provided. | |
| nireos.com | 2018 | Milan, Italy | – | – | Spectroscopic analysis solutions are delivered via Fourier-transform technology. | |
| spectophotonics.com | 2019 | Milan, Italy | $857,010 | – | Manufacturer of spectrometers for medical diagnostics | |
| h2optx.com | 2012 | San Jose, United States | – | – | Imaging solutions for pharmaceutical chemical structure analysis are provided. | |
| rigakuedxrf.com | 2009 | Austin, United States | – | – | Offers advanced X-ray metrology solutions for materials and semiconductor analysis. |
Detailed competitors of Edinburgh Molecular Imaging
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Edinburgh Molecular Imaging
Complete news archive for Edinburgh Molecular Imaging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Edinburgh Molecular Imaging
10 companies that operate in the same segment as Edinburgh Molecular Imaging (Optical & Photonics Technologies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Multiple sectors are invested in by the venture capital firm. | 1934 | Minato, Tokyo, Japan | – | USD 57.04 M | – | |
Provider of diversified optics for microscopic instruments, medical imaging systems and more | 1846 | Oberkochen, Baden-wurttemberg, Germany | USD 49.79 M | USD 2.62 B | – | |
Cloud-based network management software is provided for infrastructure planning. | 1992 | Hanover, New Hampshire, United States | – | USD 4.77 B | 8,660 | |
Fiber lasers are developed and supplied for industrial applications. | 2000 | Vancouver, Washington, United States | USD 203.65 M | USD 261.33 M | 800 | |
Photon-based universal quantum computers are developed for error correction. | 2015 | Palo Alto, California, United States | USD 2.32 B | USD 1.04 M | 12 | |
Universal quantum computers using trapped-ion technology are provided via cloud. | 2015 | College Park, Maryland, United States | USD 86 M | USD 43.07 M | 407 | |
Developer of solid-state LiDAR sensors and perception software for autonomous vehicles | 2016 | Rosh Haayin, Central District, Israel | USD 252 M | USD 55.09 M | 415 | |
Fiber-optic networking products are designed and manufactured for broadband markets. | 1997 | Sugar Land, Texas, United States | USD 64.82 M | USD 455.71 M | 3,310 | |
Data center fiber optic networks and connectivity solutions are provided. | 1991 | California, United States | – | USD 51.57 B | 37,000 | |
LiDAR-based sensors for autonomous vehicles and energy applications are developed. | 2014 | Shanghai, China | USD 598.93 M | USD 421.17 M | 1,020 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Edinburgh Molecular Imaging
Edinburgh Molecular Imaging was founded in 2014.
Edinburgh Molecular Imaging is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Bernhard Sixt is the current CEO of Edinburgh Molecular Imaging.
Edinburgh Molecular Imaging is a funded company, having raised a total of $10.68M across 4 funding rounds to date. The company's 1st funding round was a Series A of $6.54M, raised on Feb 2014.
Edinburgh Molecular Imaging was founded in 2014 in Edinburgh, United Kingdom, within the biotechnology sector. Small molecules and peptides are discovered and developed, conjugated with fluorescent dyes to target cancerous cells and diseased tissue. The imaging platform incorporates a carrier backbone for bioavailability, a peptide binder for disease-specific targeting, and a fluorescent reporter for visualization. Applications span medicinal chemistry, biochemistry, and cell biology.
Edinburgh Molecular Imaging has 3 investors. Key investors include Scottish Enterprise, European Union, and Epidarex Capital.
Edinburgh Molecular Imaging operates through Edinburgh Molecular Imaging Limited.